Coherent Market Oriented Blogs

  Neurofibromatosis type 1 is a genetic disorder that cause tumors to form on nerve tissue in the skin, brain, and other parts of the body. The condition is usually diagnosed in childhood. Bone deformities and small bumps on the iris of the eye are some of the symptoms of neurofibromatosis type 1. The condition is reported in many ethnic groups and affects males and females equally. Treatment of neurofibromatosis type-1 includes, surgery, laser or electrocautery treatment, radiation therapy, chemotherapy, or both, symptomatic, and supportive treatment. Market Dynamics Significant prevalence of neurofibromatosis type 1 is expected to propel growth of the neurofibromatosis type 1 market . For instance, as per Orphanet, a portal for rare diseases and orphan drugs, prevalence of neurofibromatosis type 1 is 1/3,000 live births. Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in 2020, the U.S. Food and Drug Administration ...